{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,3,27]],"date-time":"2025-03-27T16:48:23Z","timestamp":1743094103384,"version":"3.40.3"},"publisher-location":"Cham","reference-count":31,"publisher":"Springer International Publishing","isbn-type":[{"type":"print","value":"9783319994918"},{"type":"electronic","value":"9783319994925"}],"license":[{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018]]},"DOI":"10.1007\/978-3-319-99492-5_9","type":"book-chapter","created":{"date-parts":[[2018,8,22]],"date-time":"2018-08-22T18:14:42Z","timestamp":1534961682000},"page":"201-212","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Prediction of Drug Efficiency by Transferring Gene Expression Data from Cell Lines to Cancer Patients"],"prefix":"10.1007","author":[{"given":"Nicolas","family":"Borisov","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Victor","family":"Tkachev","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anton","family":"Buzdin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ilya","family":"Muchnik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,8,23]]},"reference":[{"key":"9_CR1","first-page":"2023","volume":"16","author":"V Vapnik","year":"2015","unstructured":"Vapnik, V., Izmailov, R.: Learning using privileged information: similarity control and knowledge transfer. J. Mach. Learn. Res. 16, 2023\u20132049 (2015)","journal-title":"J. Mach. Learn. Res."},{"key":"9_CR2","unstructured":"Lopez-Paz, D., Bottou, L., Sch\u00f6lkopf, B., Vapnik, V.: Unifying distillation and privileged information. In: ICLR 2016, San Juan, Puerto Rico (2016)"},{"key":"9_CR3","unstructured":"Xu, X., Zhou, J.T., Tsang, I., Qin, Z., Goh, R.S.M., Liu, Y.: Simple and efficient learning using privileged information (2016)"},{"key":"9_CR4","unstructured":"Celik, Z.B., Izmailov, R., McDaniel, P.: Proof and implementation of algorithmic realization of learning using privileged information (LUPI). In: Paradigm: SVM+. Institute of Networking and Security Research (INSR) (2015)"},{"key":"9_CR5","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-319-58347-1","volume-title":"Domain Adaptation in Computer Vision Applications","author":"G Csurka","year":"2017","unstructured":"Csurka, G.: Domain Adaptation in Computer Vision Applications. Springer, Cham (2017). https:\/\/doi.org\/10.1007\/978-3-319-58347-1"},{"key":"9_CR6","doi-asserted-by":"publisher","first-page":"29347","DOI":"10.18632\/oncotarget.5119","volume":"6","author":"A Artemov","year":"2015","unstructured":"Artemov, A., et al.: A method for predicting target drug efficiency in cancer based on the analysis of signaling pathway activation. Oncotarget 6, 29347\u201329356 (2015)","journal-title":"Oncotarget"},{"key":"9_CR7","unstructured":"Minsky, M.L., Papert, S.A.: Perceptrons - Expanded Edition: An Introduction to Computational Geometry. MIT Press, Boston (1987)"},{"key":"9_CR8","doi-asserted-by":"publisher","first-page":"6967","DOI":"10.1158\/1078-0432.CCR-12-1818","volume":"19","author":"GR Blumenschein","year":"2013","unstructured":"Blumenschein, G.R., et al.: Comprehensive biomarker analysis and final efficacy results of sorafenib in the BATTLE trial. Clin. Cancer Res 19, 6967\u20136975 (2013). Off. J. Am. Assoc. Cancer Res.","journal-title":"Clin. Cancer Res"},{"key":"9_CR9","first-page":"459","volume":"90","author":"LC Crossman","year":"2005","unstructured":"Crossman, L.C., et al.: In chronic myeloid leukemia white cells from cytogenetic responders and non-responders to imatinib have very similar gene expression signatures. Haematologica 90, 459\u2013464 (2005)","journal-title":"Haematologica"},{"key":"9_CR10","doi-asserted-by":"publisher","first-page":"3177","DOI":"10.1182\/blood-2006-09-044974","volume":"109","author":"G Mulligan","year":"2007","unstructured":"Mulligan, G., et al.: Gene expression profiling and correlation with outcome in clinical trials of the proteasome inhibitor bortezomib. Blood 109, 3177\u20133188 (2007)","journal-title":"Blood"},{"key":"9_CR11","doi-asserted-by":"publisher","first-page":"D955","DOI":"10.1093\/nar\/gks1111","volume":"41","author":"W Yang","year":"2013","unstructured":"Yang, W., et al.: Genomics of Drug Sensitivity in Cancer (GDSC): a resource for therapeutic biomarker discovery in cancer cells. Nucleic Acids Res. 41, D955\u2013D961 (2013)","journal-title":"Nucleic Acids Res."},{"key":"9_CR12","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1586\/epr.09.83","volume":"6","author":"X Robin","year":"2009","unstructured":"Robin, X., Turck, N., Hainard, A., Lisacek, F., Sanchez, J.-C., M\u00fcller, M.: Bioinformatics for protein biomarker panel classification: what is needed to bring biomarker panels into in vitro diagnostics? Expert Rev. Proteomics 6, 675\u2013689 (2009)","journal-title":"Expert Rev. Proteomics"},{"key":"9_CR13","unstructured":"Osuna, E., Freund, R., Girosi, F.: An improved training algorithm for support vector machines, pp. 276\u201385. IEEE (1997). http:\/\/ieeexplore.ieee.org\/document\/622408\/. Accessed 23 May 2017"},{"key":"9_CR14","doi-asserted-by":"crossref","unstructured":"Bartlett, P., Shawe-Taylor, J.: Generalization performance of support vector machines and other pattern classifiers. In: Advances in Kernel Methods. Support Vector Learn, pp. 43\u201354 (1999)","DOI":"10.7551\/mitpress\/1130.003.0007"},{"key":"9_CR15","doi-asserted-by":"publisher","first-page":"1986","DOI":"10.1093\/bioinformatics\/btr300","volume":"27","author":"L Tolo\u015fi","year":"2011","unstructured":"Tolo\u015fi, L., Lengauer, T.: Classification with correlated features: unreliability of feature ranking and solutions. Bioinformatics 27, 1986\u20131994 (2011)","journal-title":"Bioinformatics"},{"key":"9_CR16","doi-asserted-by":"crossref","unstructured":"Buzdin, A.A., et al.: Oncofinder, a new method for the analysis of intracellular signaling pathway activation using transcriptomic data. Front Genet. 5, 55 (2014)","DOI":"10.3389\/fgene.2014.00055"},{"key":"9_CR17","doi-asserted-by":"crossref","unstructured":"Buzdin, A.A., Prassolov, V., Zhavoronkov, A.A., Borisov, N.M.: Bioinformatics meets biomedicine: oncofinder, a quantitative approach for interrogating molecular pathways using gene expression data. Methods Mol. Biol. 1613, 53\u201383 (2017). Clifton NJ.","DOI":"10.1007\/978-1-4939-7027-8_4"},{"key":"9_CR18","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1007\/978-1-4939-7027-8_3","volume":"1613","author":"AM Aliper","year":"2017","unstructured":"Aliper, A.M., et al.: Mathematical justification of expression-based pathway activation scoring (PAS). Methods Mol. Biol. 1613, 31\u201351 (2017). Clifton NJ","journal-title":"Methods Mol. Biol."},{"issue":"19","key":"9_CR19","doi-asserted-by":"publisher","first-page":"1810","DOI":"10.1080\/15384101.2017.1361068","volume":"16","author":"Nicolas Borisov","year":"2017","unstructured":"Borisov, N., et al.: Data aggregation at the level of molecular pathways improves stability of experimental transcriptomic and proteomic data. Cell Cycle 16(19), 1810\u20131823 (2017). Georget Tex","journal-title":"Cell Cycle"},{"key":"9_CR20","first-page":"76","volume":"5","author":"NB Kuzmina","year":"2011","unstructured":"Kuzmina, N.B., Borisov, N.M.: Handling complex rule-based models of mitogenic cell signaling (On the example of ERK activation upon EGF stimulation). Int. Proc. Chem. Biol. Env. Eng. 5, 76\u201382 (2011)","journal-title":"Int. Proc. Chem. Biol. Env. Eng."},{"key":"9_CR21","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1002\/gcc.22149","volume":"53","author":"J Karlsson","year":"2014","unstructured":"Karlsson, J., et al.: Clear cell sarcoma of the kidney demonstrates an embryonic signature indicative of a primitive nephrogenic origin. Genes Chromosomes Cancer 53, 381\u2013391 (2014)","journal-title":"Genes Chromosomes Cancer"},{"key":"9_CR22","doi-asserted-by":"publisher","first-page":"3383","DOI":"10.1158\/1078-0432.CCR-13-0341","volume":"19","author":"M Kabbout","year":"2013","unstructured":"Kabbout, M., et al.: ETS2 mediated tumor suppressive function and MET oncogene inhibition in human non-small cell lung cancer. Clin. Cancer Res 19, 3383\u20133395 (2013). Off. J. Am. Assoc. Cancer Res.","journal-title":"Clin. Cancer Res"},{"key":"9_CR23","doi-asserted-by":"publisher","first-page":"1849","DOI":"10.1182\/blood-2003-02-0578","volume":"102","author":"T Yagi","year":"2003","unstructured":"Yagi, T., et al.: Identification of a gene expression signature associated with pediatric AML prognosis. Blood 102, 1849\u20131856 (2003)","journal-title":"Blood"},{"key":"9_CR24","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1215\/15228517-2008-113","volume":"11","author":"JG Hodgson","year":"2009","unstructured":"Hodgson, J.G., et al.: Comparative analyses of gene copy number and mRNA expression in glioblastoma multiforme tumors and xenografts. Neuro-Oncology 11, 477\u2013487 (2009)","journal-title":"Neuro-Oncology"},{"key":"9_CR25","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1186\/1471-2164-11-342","volume":"11","author":"M Bhasin","year":"2010","unstructured":"Bhasin, M., Yuan, L., Keskin, D.B., Otu, H.H., Libermann, T.A., Oettgen, P.: Bioinformatic identification and characterization of human endothelial cell-restricted genes. BMC Genom. 11, 342 (2010)","journal-title":"BMC Genom."},{"key":"9_CR26","doi-asserted-by":"publisher","first-page":"3099","DOI":"10.1016\/0006-2952(73)90196-2","volume":"22","author":"Y Cheng","year":"1973","unstructured":"Cheng, Y., Prusoff, W.H.: Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction. Biochem. Pharmacol. 22, 3099\u20133108 (1973)","journal-title":"Biochem. Pharmacol."},{"key":"9_CR27","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1080\/00031305.1992.10475879","volume":"46","author":"NS Altman","year":"1992","unstructured":"Altman, N.S.: An introduction to kernel and nearest-neighbor nonparametric regression. Am. Stat. 46, 175\u2013185 (1992)","journal-title":"Am. Stat."},{"key":"9_CR28","doi-asserted-by":"publisher","first-page":"1154","DOI":"10.1093\/bioinformatics\/btn083","volume":"24","author":"AA Shabalin","year":"2008","unstructured":"Shabalin, A.A., Tjelmeland, H., Fan, C., Perou, C.M., Nobel, A.B.: Merging two gene-expression studies via cross-platform normalization. Bioinformatics 24, 1154\u20131160 (2008)","journal-title":"Bioinformatics"},{"key":"9_CR29","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1186\/1471-2105-12-467","volume":"12","author":"J Rudy","year":"2011","unstructured":"Rudy, J., Valafar, F.: Empirical comparison of cross-platform normalization methods for gene expression data. BMC Bioinform. 12, 467 (2011)","journal-title":"BMC Bioinform."},{"key":"9_CR30","first-page":"2311","volume":"8","author":"Q Wang","year":"2015","unstructured":"Wang, Q., Liu, X.: Screening of feature genes in distinguishing different types of breast cancer using support vector machine. OncoTargets Ther. 8, 2311\u20132317 (2015)","journal-title":"OncoTargets Ther."},{"key":"9_CR31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1145\/1961189.1961199","volume":"2","author":"C-C Chang","year":"2011","unstructured":"Chang, C.-C., Lin, C.-J.: LIBSVM: a library for support vector machines. ACM Trans. Intell. Syst. Technol. 2, 1\u201327 (2011)","journal-title":"ACM Trans. Intell. Syst. Technol."}],"container-title":["Lecture Notes in Computer Science","Braverman Readings in Machine Learning. Key Ideas from Inception to Current State"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-3-319-99492-5_9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,13]],"date-time":"2024-03-13T11:56:00Z","timestamp":1710330960000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-3-319-99492-5_9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018]]},"ISBN":["9783319994918","9783319994925"],"references-count":31,"URL":"https:\/\/doi.org\/10.1007\/978-3-319-99492-5_9","relation":{},"ISSN":["0302-9743","1611-3349"],"issn-type":[{"type":"print","value":"0302-9743"},{"type":"electronic","value":"1611-3349"}],"subject":[],"published":{"date-parts":[[2018]]},"assertion":[{"value":"23 August 2018","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}},{"value":"The authors declare no conflicts of interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosure of Interests"}}]}}